| 28 Nov, 11:42 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 28 Nov, 11:38 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated November 28, 2025, titled "Lupin Foundation Earns CRISIL s Highest VO 1A Rating for Excellence in Social Responsibility". | nse |
| 21 Nov, 10:48 pm | — | … | Lupin Limited has informed the Exchange about U.S. FDA has conducted an inspection at Company's manufacturing facility located at Goa, India. | nse |
| 15 Nov, 04:54 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated November 15, 2025, titled "Lupin Announces Closure of Inspection by U.S. FDA at its Nagpur Unit-1 Facilitywith No Observations". | nse |
| 15 Nov, 04:53 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 14 Nov, 07:22 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 14 Nov, 07:16 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated November 14, 2025, titled "Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere". | nse |
| 13 Nov, 12:42 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Lupin Establishes a New Global Standard in Sustainable Pharma with an S&P Global ESG Score of 91". | nse |
| 13 Nov, 12:40 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 12 Nov, 10:24 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 12 Nov, 10:22 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "Lupin Receives EIR from U.S. FDA for its Aurangabad (CSN) Facility". | nse |
| 12 Nov, 04:00 pm | — | … | Lupin Limited has informed the Exchange about Transcript of Q2 FY2026 Earnings Conference Call. | nse |
| 12 Nov, 03:58 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 12 Nov, 12:58 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "Lupin Manufacturing Solutions Unveils Dedicated Oncology Block at Vizag, India". | nse |
| 12 Nov, 12:57 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Nov, 04:13 pm | — | … | Lupin Limited has informed the Exchange about participating in the Analyst/Investors Meet. | nse |
| 08 Nov, 12:05 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated November 08, 2025, titled "Lupin Bioresearch Center Receives Zero Observations from U.S. FDA After SuccessfulInspection and Assessment". | nse |
| 08 Nov, 12:05 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 08 Nov, 11:58 am | — | … | Lupin Limited has informed the Exchange about Copy of Newspaper Publication in respect of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025. | nse |
| 07 Nov, 06:06 pm | — | … | Lupin Limited has informed the Exchange about Link of Audio Recording of the Earnings Call-Q2 FY26. | nse |
| 07 Nov, 06:06 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 06 Nov, 07:16 pm | — | … | Lupin Limited has informed the Exchange about Investor Presentation | nse |
| 06 Nov, 07:14 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 06 Nov, 06:53 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated November 06, 2025, titled "Lupin Q2 FY2026 Results". | nse |
| 06 Nov, 06:51 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Nov, 06:34 pm | — | … | Lupin Limited has submitted to the Exchange about Outcome of the Board Meeting for approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended September 30, 2025 | nse |
| 06 Nov, 06:30 pm | — | … | Lupin Ltd - 500257 - Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025. | bse |
| 05 Nov, 05:52 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Nov, 05:48 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "Lupin Receives EIR from U.S. FDA for its Pithampur Unit-3 Facility". | nse |
| 30 Oct, 01:52 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated October 30, 2025, titled "Lupin Digital Health Launches VITALYFE ". | nse |
| 30 Oct, 01:52 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 28 Oct, 03:54 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 28 Oct, 03:51 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated October 28, 2025, titled "Inauguration of Lupin s New Corporate Offices in Bridgewater, New Jersey". | nse |
| 27 Oct, 05:53 pm | — | … | Lupin Limited has informed the Exchange about Schedule of Earnings Call for Unaudited Financial Results of Q2 FY26. | nse |
| 24 Oct, 09:37 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Oct, 09:33 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated October 24, 2025, titled "Lupin Launches Authorized Generic Version of Ravicti® in the United States". | nse |
| 22 Oct, 04:25 pm | — | … | Lupin Ltd - 500257 - Board Meeting Intimation for Considering And Taking On Record The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025. | bse |
| 13 Oct, 02:49 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated October 13, 2025, titled "Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at theESMO Congress 2025". | nse |
| 13 Oct, 02:48 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 11 Oct, 12:06 pm | — | … | Lupin Limited has informed the Exchange about U.S. FDA has conducted a Pre-Approval Inspection at Company's manufacturing facility located in Somerset, New Jersey, U.S.A. | nse |
| 09 Oct, 03:04 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 09 Oct, 03:01 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated October 09, 2025, titled "Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform". | nse |
| 08 Oct, 06:30 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 08 Oct, 06:30 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated October 08, 2025, titled "Lupin Announces Plans to Build a New State-of-the-Art Manufacturing Facility in Coral Springs, Florida, U.S.A.". | nse |
| 04 Oct, 12:24 pm | — | … | Lupin Limited has informed the Exchange that U.S. FDA has determined the inspection of Company's Pithampur Unit-2 manufacturing facility as Official Action Indicated. | nse |
| 03 Oct, 06:13 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated October 03, 2025, titled "Lupin Launches Liraglutide Injection in the United States". | nse |
| 03 Oct, 06:12 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 01 Oct, 03:02 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated October 01, 2025, titled "Lupin Launches Rivaroxaban for Oral Suspension in the United States". | nse |
| 01 Oct, 03:01 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 30 Sept, 04:57 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated September 30, 2025, titled "Lupin Receives Approval from U.S. FDA for Rivaroxaban for Oral Suspension ". | nse |